The adoption of the merger agreement was approved by
About
Contact:
Tel: +45 30 79 38 83
Email: mkd@novonordisk.com
(C) 2020 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
980.3 DKK | +1.34% |
|
+0.65% | +40.42% |
Jul. 12 | Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market | RE |
Jul. 12 | Ozempic linked with lower dementia risk, nicotine use, British study finds | RE |
The adoption of the merger agreement was approved by
About
Contact:
Tel: +45 30 79 38 83
Email: mkd@novonordisk.com
(C) 2020 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+40.42% | 625B | |
+62.66% | 841B | |
-4.37% | 360B | |
+17.16% | 327B | |
+9.87% | 300B | |
+15.66% | 242B | |
+17.90% | 227B | |
+14.86% | 174B | |
+0.45% | 162B | |
+5.17% | 127B |